Calendar

Cloudflare’s reported Q2 2026 revenue growth and a $736.8M Q3 revenue consensus provide a credible business backdrop, but the stock fell sharply into the event: it lost roughly 15.5% from Oct. 26 to Oct. 30, including a high-volume down day. Required positive tape and estimate-upside signals are not supported.

ABNB has a small positive whisper-versus-consensus gap and recent company guidance describes strong revenue growth, but the guidance midpoint is slightly below the checked revenue consensus. The stock fell about 4.4% over five sessions, had no close above the 0.75 close-location threshold in the latest three sessions, and no confirmed 1.5x volume session; it does not qualify despite a supportive XLY tape.

EOG has upward EPS estimate revisions, a credible Q3 consensus, and a strong Oct. 30 close, but available checks did not establish positive revenue revisions or a recent >1.5x-volume accumulation day. The company has scheduled its Q3 results for Nov. 5 after close; its IR page separately lists a Nov. 6 results call.

Lumentum's September-quarter EPS estimate rose from $4.21 to $4.22 over the last month, and its prior company guidance midpoint for $1.25B revenue is in line with reported consensus; management cited accelerating AI-driven optical demand and the stock advanced sharply over the preceding five sessions. However, the late-week reversal and lack of a verified normal-volume comparator temper the setup, while valuation and execution risks remain material.

Simon has positive, though non-uniform, estimate momentum: checked consensus showed EPS up 1.74% and revenue up 3.69% over three months, and its latest reported quarter showed 96.0% occupancy, higher retailer sales, and raised full-year FFO guidance. The stock gained about 2.4% over five sessions and closed near the top of its Oct 30 range, but a normal-volume comparison was unavailable and its recent earnings history is uneven.

DVN has positive near-term estimate revisions, rising revenue expectations, four recent EPS beats per Zacks, and an official Nov. 5 reporting date; the stock also strengthened into the event. However, earnings-whisper EPS is below some consensus figures and the shares lagged the energy sector over the past month, while commodity exposure and transaction execution leave meaningful uncertainty.

Earnings Whispers reports a $1.48 whisper against $1.39 consensus, while the prior quarter had strong reported growth; however, no reliable pre-event revenue-revision, verified close-location, or volume-accumulation evidence was found for this screen, and the supplied latest close does not establish recent strength. The positive whisper alone is insufficient for qualification.

ED's reported date and consensus figures were available, and the recent close rose with XLU supportive; Con Edison had reaffirmed its 2026 adjusted EPS guidance. But no positive EPS revision, ESP, whisper, or revenue-upside signal was verified, and none of the last three checked sessions closed in the upper quarter of its range.

A pre-event Zacks article says the estimate-revision combination points toward a likely EPS beat, and recent annualized recovery expectations offer a possible cyclical catalyst. However, exact revision and current-quarter revenue consensus/upside evidence was not verifiable in the checked results, while Oct. 30 brought a high-volume 4.66% selloff and a weak close; it fails the required tape confirmation.

Live Nation has strong operating indicators ahead of the report: the latest available filing said 2026 event ticket sales were pacing 11% higher and deferred revenue reached a second-quarter record, while the stock recovered into Oct. 30 on a large-volume up day. But current-quarter revenue consensus estimates varied across checked providers and no positive EPS revision/ESP/whisper was verified; score remains below the required threshold.

The supplied Nov. 5 date conflicts with checked earnings sources: Earnings Whispers and MarketBeat indicate Nov. 4, while another estimate page shows Nov. 5 and cautions the date may move. Consensus estimates exist, but no positive revisions or required tape confirmation were established; reject on unconfirmed event date and incomplete signals.

MRNA has a modestly favorable EPS revision snapshot and a recent high-volume rebound, but the checked calendar sources describe Nov. 6 as estimated rather than company-confirmed, and no positive revenue revision or upside indicator was verified. The Oct. 22 melanoma-trial data leak coincided with a 17.57% drop and unusually high volume, leaving a volatile, event-driven tape.

Record Q2 fundraising and 20% fee-related-earnings growth, alongside a rising recent share price and several analyst target cuts, create a constructive but mixed backdrop. The checked sources support EPS and revenue consensus, but do not establish positive estimate revisions or an upside surprise signal; recent volume also falls short of a verified accumulation trigger.

Humana's primary IR estimate table showed near-flat Q3 EPS revisions and a credible consensus source provides EPS and revenue estimates, but the stock weakened into the event and underperformed the rising XLV. Medical-cost and Medicare policy uncertainty remain material, while recent tape did not confirm accumulation.

Vistra has a company-confirmed Nov. 6 report date and a strongly positive 30-day Q3 EPS revision, alongside long-term power-demand catalysts. However, shares declined about 5.4% from Oct. 26 through Oct. 30, recent closes were weak in their daily ranges, and the latest quarter missed consensus materially. Positive revisions alone do not offset the poor pre-event tape and limited recent execution evidence.

The earnings beat and higher RBC EPS estimates are positive, but reaction was mixed: packet coverage described a 1.58% premarket decline on October 15, while Benzinga reported a 0.78% gain in early October 16 trading. The October 19 anchor was $142.44; available evidence does not establish a sustained post-print rerating. Citi and Truist cut targets, Morgan Stanley raised its target marginally, and RBC held its target. Social, options, short-interest, and employee measures were not supplied; their zero placeholders are unavailable data, not neutral observations. [Benzinga](https://www.benzinga.com/analyst-stock-ratings/analyst-color/26/10/62417399/bnys-transformation-continues-to-deliver-strong-results-analyst-says-after-q3-beat)

News tone is constructive on the beat, but the closing-price response did not hold: CMC closed at $65.37 on October 15 and $64.54 on October 19, about 1.1% below its October 14 pre-release close of $65.29. That price path does not establish why shares moved. Post-print analyst targets include two cuts and one raise, and comparable forward-estimate revisions were not verified; neither missing revisions nor the initial intraday rise is positive evidence. [Price history](https://stockanalysis.com/stocks/cmc/history/); [analyst-target history](https://stockanalysis.com/stocks/cmc/forecast/). Social, options, short-interest and employee metrics were unavailable, so their numerical placeholders above should not be interpreted as observed readings.

The initial reaction was favorable: AA closed up about 2.6% on October 16, then the packet anchors it at $41.67 on October 19. That modest gain has not resolved the mixed print: an EPS beat, revenue miss, softer sequential EBITDA and several post-print target cuts. Reliable forward-estimate changes were not established. Social, options, short-interest and employee measures are unavailable; zero entries above are missing-data placeholders, not neutral readings. [October 16 price record](https://markets.ft.markitdigital.com/data/equities/tearsheet/forecasts?s=AA%3ANYQ) [Analyst target history](https://stockanalysis.com/stocks/aa/forecast/)

Earnings coverage is mildly constructive but mixed: Benzinga reported PNC up 0.8% at $216.56 during October 16 trading, versus the packet's October 19 adjusted-close anchor of $216.21; a comparable close-to-close post-print reaction is unavailable. The reported analyst target changes split one increase against two cuts, so the initial beat has not produced a uniform revision signal. Social, options, short-interest and employee inputs are unavailable; zero entries are missing-data placeholders, not observed readings. [Post-print coverage](https://www.benzinga.com/news/26/10/62418685/these-analysts-revise-their-forecasts-on-pnc-financial-after-q3-results)

No Q3 price reaction or earnings surprise can be assessed before the announced October 27 release [#PR-EARNINGS-2026-10-13]. The October 19 packet anchor is $124.46. Q2 evidence remains constructive, but October analyst target cuts are a negative pre-print revision signal. Social, options, short-interest, and employee measures are unavailable; the zero entries above denote missing data, not neutral observed readings.

The October 19 anchor of $26.46 is about 13% below the prior baseline's October 1 anchor of $30.48, but this is not a Q3 post-earnings return: Whirlpool says Q3 results are due October 26. The October 16 target cut and October 19 downgrade are therefore pre-print caution, not delayed post-print revisions. Q3 consensus surprise and market reaction are unavailable. Zero-valued social, options, short-interest, employee, and news-sentiment fields indicate unavailable measurements, not neutral readings. [#IR-2026-10-19] [Analyst-action listing](https://www.benzinga.com/quote/whr/price-targets)